Tramadol Recall – risk of fungal contamination

As a firm of specialist injury lawyers who represent a lot of victims for medical and product related claims, we often blog about recalls that may result in harm to users. In a new report from the Medicines and Healthcare Products Regulatory Agency (MHRA), all batches of 50mg Tramadol manufactured by RelonChem Ltd/ Kent Pharmaceuticals are being immediately recalled.

The risk, according to the MHRA, is fungal contamination.

Whilst this is notable primarily for pharmaceutical firms and doctors, any person who has recently obtained a pack will need to know that there is a risk of fungal contamination. The MHRA as the responsible body for investigating products and incidents, as well as for publicising about them, have advised that all unexpired stocks of the medication need to be recalled.

You can find more information and the alert notification on the MHRA website here.

Fungal contamination can cause serious disease and illness – it’s important that these products are recalled quickly and efficiently.